IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q4 2025 Holdings

Filed 2026-02-13 | 9 holdings | $137.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$96.3M5,664,54870.0%
Invivyd Inc(IVVD)COM00534A102$22.8M9,248,25016.6%
TG Therapeutics Inc(TGTX)COM88322Q108$4.8M161,6003.5%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$4.5M67,4003.3%
Fractyl Health Inc(GUTS)COM35168W103$4.1M1,856,1173.0%
Proqr Thrapeutics N VSHS EURON71542109$2.1M1,019,4981.5%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$1.4M385,6801.0%
Silence Therapeutics PLC(SLN)ADS82686Q101$1.1M185,1000.8%
Curis Inc(CRIS)COM231269309$514.3K521,0590.4%